Hedge Fund - Casdin Capital
Fate Therapeutics Inc (FATE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $7,667,000 | 0.75% | 2,050,000 | $2.36 |
| 2 | 2023 - Q3 (2023-09-30) | $4,346,000 | 0.48% | 2,050,000 | $3.31 |
| 3 | 2023 - Q2 (2023-06-30) | $9,758,000 | 0.85% | 2,050,000 | $5.52 |
| 4 | 2023 - Q1 (2023-03-31) | $11,685,000 | 0.96% | 2,050,000 | $6.03 |
| 5 | 2022 - Q4 (2022-12-31) | $20,684,500 | 1.6% | 2,050,000 | $18.78 |
| 6 | 2022 - Q3 (2022-09-30) | $45,941,000 | 3.01% | 2,050,000 | $28.89 |
| 7 | 2022 - Q2 (2022-06-30) | $52,038,000 | 4.39% | 2,100,000 | $27.59 |
| 8 | 2022 - Q1 (2022-03-31) | $131,818,000 | 5.91% | 3,400,000 | $38.72 |
| 9 | 2021 - Q4 (2021-12-31) | $198,934,000 | 5.6% | 3,400,000 | $56.68 |
| 10 | 2021 - Q3 (2021-09-30) | $201,518,000 | 5.01% | 3,400,000 | $78.44 |
| 11 | 2021 - Q2 (2021-06-30) | $295,086,000 | 7.49% | 3,400,000 | $80.58 |
| 12 | 2021 - Q1 (2021-03-31) | $280,330,000 | 8.34% | 3,400,000 | $95.82 |
| 13 | 2020 - Q4 (2020-12-31) | $277,337,000 | 8.21% | 3,050,000 | $62.10 |
| 14 | 2020 - Q3 (2020-09-30) | $121,909,000 | 5.45% | 3,050,000 | $34.92 |
| 15 | 2020 - Q2 (2020-06-30) | $104,646,000 | 6.19% | 3,050,000 | $29.80 |
| 16 | 2020 - Q1 (2020-03-31) | $56,636,000 | 6.01% | 2,550,000 | $25.29 |
| 17 | 2019 - Q4 (2019-12-31) | $49,904,000 | 4.58% | 2,550,000 | $15.88 |
| 18 | 2019 - Q3 (2019-09-30) | $39,601,500,000 | 4.09% | 2,550,000 | $19.17 |
| 19 | 2019 - Q2 (2019-06-30) | $51,765,000,000 | 4.84% | 2,550,000 | $18.02 |
| 20 | 2019 - Q1 (2019-03-31) | $44,804,000 | 4.92% | 2,550,000 | $15.78 |
| 21 | 2018 - Q4 (2018-12-31) | $32,717,000 | 5.59% | 2,550,000 | $13.94 |
| 22 | 2018 - Q3 (2018-09-30) | $41,540,000 | 5.04% | 2,550,000 | $11.83 |
| 23 | 2018 - Q2 (2018-06-30) | $29,484,000 | 4.12% | 2,600,000 | $11.02 |
| 24 | 2018 - Q1 (2018-03-31) | $25,376,000 | 4.46% | 2,600,000 | $9.58 |
| 25 | 2017 - Q4 (2017-12-31) | $15,886,000 | 3.86% | 2,600,000 | $4.46 |
| 26 | 2017 - Q3 (2017-09-30) | $2,178,000 | 0.61% | 550,000 | $3.40 |
| 27 | 2017 - Q2 (2017-06-30) | $1,782,000 | 0.65% | 550,000 | $3.83 |
The displayed share prices are average quarterly stock market prices.